Pacific Ethanol, Inc. produces and sells low carbon renewable fuels in the Western United States. The company produces and sells ethanol and its co-products, including wet distillers grain and provides transportation, storage and delivery of ethanol through third-party service providers in the Western United States, primarily in California, Nevada, Arizona, Oregon, Colorado, Idaho and Washington. On May 17, 2009, five of Pacific Ethanol, Inc. wholly owned subsidiaries, Pacific Ethanol Holding Co. LLC, Pacific Ethanol Madera LLC, Pacific Ethanol Columbia, LLC, Pacific Ethanol Stockton, LLC and Pacific Ethanol Magic Valley, LLC, each commenced a case by...
read more
Pacific Ethanol Inc. (NASDAQ:PEIX) is on something of a run at the moment. In about a month, PEIX has gone from around $0.30 to nearly $1.30.read more
Pacific Ethanol, Inc. (NASDAQ:PEIX) entered the market with a large gap up yesterday, which in addition to its spectacular volume gain, made the stock the subject of several investor alerting stock newsletters.read more
Stocks To Buy Forum
Stocks to Buy Today - Stock Message Board, Discussion Forum, Blog
A message to all members of Stocks To Buy Forum
I did some stock analysis on Pacific Ethanol (PEIX) tonight as I am watching several key levels. In the next day or two, price will tell me what to do next. Do I sell or buy more? I am watching the key level of $1.29 as well as the 200 day moving average which will most likely be down to $1.33 read more
TSPT, Transcept Pharmaceuticals, Inc.
** TSPT reported that Purdue has exercised its option to commercialize Intermezzo in the United States. Purdue plans to launch Intermezzo in the second quarter of 2012 and to invest approximately $100 million to support sales and marketing during the first year of commercialization.
On November 23, 2011 , the FDA approved Intermezzo (zolpidem tartrate) sublingual tablet C-IV for use as needed read more
TSPT, Transcept Pharmaceuticals, Inc.
** TSPT reported that Purdue has exercised its option to commercialize Intermezzo in the United States. Purdue plans to launch Intermezzo in the second quarter of 2012 and to invest approximately $100 million to support sales and marketing during the first year of commercialization.
On November 23, 2011 , the FDA approved Intermezzo (zolpidem tartrate) sublingual tablet C-IV for use as needed read more
To see the headquarters in Google Street View &trade, drag this yellow guy: 
over to the red pointer: 
